Covid-19
Matawalle receives first dose of COVID-19 vaccine in Gusau
Gov. Bello Matawalle of Zamfara on Monday at the Government House, Gusau, received his first dose of AstraZeneca vaccine against Coronavirus (COVID-19).
The News Agency of Nigeria (NAN) reports that the vaccine was administered on the governor by the Commissioner of Health, Alhaji Yahaya Kanoma.
NAN reports that the state had last week, received 55,920 doses of the vaccine from the Federal Government.
Matawalle urged people of the state to believe in the vaccine and make themselves available for vaccination against the dreaded coronavirus.
The governor, after taking the vaccine reassured that the state government would stop the spread of the COVID-19 in the 14 local government areas of the state.
“I just took my first dose of Oxford-AstraZeneca. I am appealing to the people of this state to make themselves available for the vaccine.
“Apart from me, all government officials would also receive the vaccine.
“We are going to distribute the vaccine to the security and Federal Government agencies in the state,” he said.
NAN further reports that the Speaker of Zamfara State House of Assembly, Alhaji Nasiru Magarya and Deputy Chief of Staff to the governor, Dr Bashir Maru, also received the vaccine at the event.
-
Latest3 days agoFull List: Meet the 2026 Nobel Prize winners across six categories
-
Featured1 week ago103 Million Voters: What does INEC’s new register say about Nigeria’s population?
-
Football3 days agoPremier League Matchweek 7: Five Fixtures That Could Shape the Weekend
-
Business1 week agoThe Ministry of Commerce of Loveworld gets a $1 million boost for new investment fund at LTIF 2026 to promote Trade in Ghana
-
Latest3 days agoUmahi defends Lagos-Calabar highway route changes amid public outcry
-
Features1 week agoEdo’s 2.5 million vote promise: Can the numbers match the politics?
-
Business2 days agoDangote Refinery IPO Extension: Was the 70% subscription report overhyped?
-
Business2 days agoDangote Refinery IPO: 70% Subscription claim meets fourfold demand assertion as investors seek clarity


